account_balance
Investment manager · 13F filer · SEC CIK 2104501
Remedium Capital Partners, LLC
Reported value$274Mas of Sep 30, 2026
Positions6 1 new, 1 sold out
Top 10 weight100.0%SYRE alone is 38%
FiledNov 1344 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 6 stocks.
SYRESpyre Therapeutics, Inc.
37.8%Trimmed −21%
ORKAOruka Therapeutics, Inc.
29.0%Trimmed −39%
DMRADamora Therapeutics, Inc.
15.9%
JBIOJade Biosciences, Inc.
9.3%Added +15%
KRSAKorsana Biosciences, Inc.
6.1%New
CBIO1.9%SYRESpyre Therapeutics, Inc.
37.8%Trimmed −21%
ORKAOruka Therapeutics, Inc.
29.0%Trimmed −39%
DMRADamora Therapeutics, Inc.
15.9%
JBIOJade Biosciences, Inc.
9.3%
KRSAKorsana Biosciences, Inc.
6.1%
CBIOBox size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed
Biggest moves since Jun 30, 2026
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.